221Indexed trials
mesh condition
Depressive Disorder, Major
Intelligence
Depressive Disorder, Major intelligence: 221 indexed trials, 44 recruiting studies, 148 sponsors across 51 countries.
44Recruiting
148Sponsors
51Countries
Leading sponsors
University of California, Los Angeles90 recruiting
Massachusetts General Hospital61 recruiting
Eli Lilly and Company50 recruiting
Pfizer40 recruiting
H. Lundbeck A/S40 recruiting
Janssen Research & Development, LLC40 recruiting
Yale University42 recruiting
Forest Laboratories40 recruiting
National Institute of Mental Health (NIMH)42 recruiting
Naurex, Inc, an affiliate of Allergan plc30 recruiting
New York State Psychiatric Institute30 recruiting
AbbVie30 recruiting
Geographic activity
United States117trials
Canada24trials
Germany15trials
France11trials
Spain11trials
Italy10trials
South Korea9trials
Taiwan7trials
United Kingdom7trials
China7trials
Japan7trials
Netherlands6trials
Leading interventions
Escitalopram8trials
Transcranial Magnetic Stimulation7trials
Ketamine5trials
Vortioxetine5trials
Fluoxetine4trials
Ketamine Hydrochloride4trials
Sham Stimulation4trials
Sertraline4trials
Duloxetine Hydrochloride3trials
Midazolam3trials
Rapastinel3trials
Intermittent Theta Burst Stimulation (iTBS)2trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.